Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
Hematologic Oncology Update
00:00
Intro
This chapter reviews recent advancements in chronic lymphocytic leukemia (CLL) management, highlighting new therapies like BTK inhibitors and venetoclax. The speakers also compare these modern treatments to traditional methods and discuss their impact on patient survival and quality of life.
Transcript
Play full episode
